Skip to main content
UniHealth

Doctor search

Ramona L Doyle, MD

Pulmonary Disease · San Francisco

NPI 1497863567

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
12
2 carriers
Office
1

Offices

1 location · University of California San Francisco · 1,780 clinicians in this group

Looking this up.

Hospitals listed: UCSF Medical Center · Zuckerberg San Francisco General Hosp & Trauma Ctr. That is not proof they admit you there this week.

Plans that list them

12 plans · 2 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Doyle’s office at (415) 476-1000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

12 of 12 plans

Plans whose provider directory lists this clinician
Alignment Health BreathEasy (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Clarity (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Harmony (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Honor+ Plan (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health My Choice CalCare (HMO)Alignment Health PlanListedOct 3, 2026
Imperial Courage Plan (HMO)Imperial Health Plan of California, Inc.ListedSep 1, 2026
Imperial Dynamic Plan (HMO)Imperial Health Plan of California, Inc.ListedSep 1, 2026
Imperial Senior Value (HMO C-SNP)Imperial Health Plan of California, Inc.ListedSep 1, 2026

California Medical Board record

Licence G68150 · Current

Licensed to practise in California · since 1990 · expires 2028-01-31 · Emory University School of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

2 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • UCSF Medical CenterSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of UCSF Helen Diller Family Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 81% would definitely recommend it
    Overall rating: 4 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 4.9 (3.79 to 6.02) · 7,590 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 12.8 (11.3 to 14.4) · 2,019 cases, Jan 2024 – Dec 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 139.4 (110.22 to 168.58) · 452 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.622, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.626, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.491, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 1) · 2,336 cases, Jan 2024 – Dec 2024
  • Zuckerberg San Francisco General Hosp & Trauma CtrSan Francisco, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of San Francisco Health Network, which runs 2 hospitalsPatients rate it 3 of 5 · 72% would definitely recommend it
    Overall rating: 2 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.449, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.37, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.538, Oct 2024 – Sep 2025
See every measure and the patient survey for UCSF Medical Center

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 3 better, 5 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at UCSF Medical Center
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths4.9 (3.79 to 6.02) · 7,590 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits12.8 (11.3 to 14.4) · 2,019 casesWorseJan 2024 – Dec 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths139.4 (110.22 to 168.58) · 452 casesBetterJul 2022 – Jun 2024
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.622BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.626BetterOct 2024 – Sep 2025
MRSA BacteremiaInfections0.491BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.8 (0.7 to 1) · 2,336 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.24 (0.58 to 1.9) · 4,689 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths1.05 (0.89 to 1.2)No differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.9 · 89 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths7.5 · 85 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths10.1 · 132 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.6 · 454 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 618 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths9.6 · 380 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.7 · 5,000 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.22 (0.06 to 0.38) · 15,965 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.2 (0.05 to 0.35) · 17,859 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.85 (0 to 1.83) · 4,184 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2 (1.1 to 2.9) · 6,516 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths7.35 (4.49 to 10.21) · 3,989 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5 (3.22 to 6.77) · 4,087 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.95 (0.74 to 3.15) · 2,034 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.95 (0.63 to 1.28) · 15,431 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4 · 399 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.899No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.689No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections1.224No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16 · 156 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20 · 564 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits60.3 · 160 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-9.7 · 550 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits44.1 · 660 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.8 · 667 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.7 (4.8 to 6.7) · 2,019 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits6 · 421 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.5 · 53 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits20 · 107 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits13.9 (11.3 to 17.1) · 3,247 casesNo differentJan 2022 – Dec 2024

What patients said (3,181 patients answered, 25% of those asked)

Patient survey stars by topic at UCSF Medical Center
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at UCSF Medical Center
Room was "always" clean71%
Nurses "always" communicated well80%
Doctors "always" communicated well80%
Staff "always" explained61%
Yes, staff "did" give patients this information88%
Yes, staff "did" give patients information about help after discharge87%
Doctors "always" explained things so they could understand74%
Doctors "always" listened carefully78%
Doctors "always" treated them with courtesy and respect86%
Patients who gave a rating of "9" or "10" (high)76%
Staff "always" explained new medications75%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully78%
Nurses "always" treated them with courtesy and respect86%
"Always" quiet at night50%
"YES", patients would definitely recommend the hospital81%
Staff "always" explained possible side effects46%
Yes, staff "did" give patients information about possible symptoms90%
See every measure and the patient survey for Zuckerberg San Francisco General Hosp & Trauma Ctr

Behind the star rating — Deaths: 1 better, 6 the same, 0 worse of 7 measures. Safety: 1 better, 5 the same, 1 worse of 7 measures. Readmissions: 0 better, 7 the same, 2 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Zuckerberg San Francisco General Hosp & Trauma Ctr
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.449BetterOct 2024 – Sep 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.37BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.538BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.9 (0 to 1.91) · 667 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths1.12 (0.76 to 1.49)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths195.34 (147.34 to 243.34) · 76 casesNo differentJul 2022 – Jun 2024
Death rate for COPD patientsComplications and deaths7.2 · 114 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths12.2 · 48 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths7.5 · 201 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths14.5 · 214 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths10.3 · 261 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3.5 · 1,351 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.29 (0.07 to 0.5) · 4,709 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.39 (0.19 to 0.59) · 4,644 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths4.34 (2.11 to 6.56) · 795 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.59 (0 to 3.28) · 234 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.85 (1.33 to 4.38) · 861 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths8.95 (0.25 to 17.64) · 261 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths6 (2.01 to 9.98) · 242 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.66 (0.17 to 3.14) · 167 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.79 (0.08 to 1.49) · 4,129 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4.4 · 35 casesNoneApr 2023 – Mar 2025
MRSA BacteremiaInfections0.709No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections1.769No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits14.7 · 41 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits22.1 · 227 casesNoneJul 2023 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits28.6 · 257 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits75.1 · 239 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits18.2 · 232 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits6.8 (4.7 to 9.6) · 175 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits11.3 (8.3 to 15.1) · 175 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits6.1 · 37 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits20.2 · 132 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits13.6 (10.4 to 17.9) · 966 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1.2 (0.8 to 1.7) · 88 casesNo differentJan 2024 – Dec 2024

What patients said (1,644 patients answered, 16% of those asked)

Patient survey stars by topic at Zuckerberg San Francisco General Hosp & Trauma Ctr
Cleanliness4
Nurse communication2
Doctor communication3
Communication about medicines2
Discharge information3
Overall hospital rating4
Quietness3
Recommend hospital4
Share of patients giving the best answer at Zuckerberg San Francisco General Hosp & Trauma Ctr
Room was "always" clean69%
Nurses "always" communicated well73%
Doctors "always" communicated well75%
Staff "always" explained56%
Yes, staff "did" give patients this information84%
Yes, staff "did" give patients information about help after discharge83%
Doctors "always" explained things so they could understand68%
Doctors "always" listened carefully75%
Doctors "always" treated them with courtesy and respect82%
Patients who gave a rating of "9" or "10" (high)72%
Staff "always" explained new medications67%
Nurses "always" explained things so they could understand68%
Nurses "always" listened carefully70%
Nurses "always" treated them with courtesy and respect80%
"Always" quiet at night55%
"YES", patients would definitely recommend the hospital72%
Staff "always" explained possible side effects44%
Yes, staff "did" give patients information about possible symptoms84%

Original Medicare doctor bills

$3,417

Medicare paid this office $3,417 for 24 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Return visit (30+ min)22$2,401$75

Who their Medicare patients are

24 Original Medicare patients in 2024. Average age 71 · Health risk score 2.35. Above the middle of the specialty; the typical pulmonary disease clinician is at 2.13.

Conditions among them: High blood pressure 75% · COPD 58% · Heart failure 50%.

The office billed $25,093, Medicare allowed $4,696 and paid $3,417; for 43 services of 5 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
20242443712.35$25,093$3,417
20232347712.53$28,970$4,292
20223048692.12$23,368$3,938
20212741672.39$21,587$3,218
20202342652.70$24,779$3,136
20191727632.04$20,595$2,363
20182646642.15$33,159$4,225
20172438642.29$24,378$3,280
20162855642.39$34,227$4,593
20152751622.03$33,506$4,675
20142334651.90$23,234$3,280
20133252621.74$32,681$4,684

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 1 service

Original Medicare services billed in 2023
Return visit (30+ min)19$3,070$85

2022: 1 service

Original Medicare services billed in 2022
Return visit (30+ min)17$1,834$87

2021: 1 service

Original Medicare services billed in 2021
Return visit (30+ min)17$1,506$68

2020: 1 service

Original Medicare services billed in 2020
Return visit (30+ min)18$2,223$72

2019: 1 service

Original Medicare services billed in 2019
Long return visit (40+ min)16$1,999$87

2018: 1 service

Original Medicare services billed in 2018
Long return visit (40+ min)19$2,931$92

2017: 2 services

Original Medicare services billed in 2017
Long return visit (40+ min)18$2,286$95
Return visit (30+ min)11$844$65

2016: 2 services

Original Medicare services billed in 2016
Long return visit (40+ min)12$2,151$98
Return visit (30+ min)21$1,727$64

2015: 2 services

Original Medicare services billed in 2015
Long return visit (40+ min)19$2,868$96
Return visit (30+ min)12$1,048$70

2014: 1 service

Original Medicare services billed in 2014
Long return visit (40+ min)18$2,478$95

2013: 1 service

Original Medicare services billed in 2013
Long return visit (40+ min)16$2,496$92

Drugs they prescribed that Part D paid

$1,124,733

Pharmacies billed $1,124,733 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

59 generic and 67 brand-name prescriptions · $1,124,733 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Uptravi17$434,806$25,577
Opsumit29$353,412$12,187
Ambrisentan13$99,622$7,663

Year by year

Part D prescribing by year
202412623None53%$1,124,733
2023113240% (0)58%$1,024,990
2022113150% (0)50%$1,170,541
2021111120% (0)55%$1,055,600
2020172200% (0)47%$1,357,206
2019341280% (0)42%$2,056,284
201848330None55%$2,696,990
201719520None73%$1,560,728
2016165190% (0)78%$951,055
2015278220% (0)67%$960,558
201428221None56%$678,480
201330829None43%$457,292

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 4 drugs

Part D drugs prescribed in 2023
Tyvaso Dpi16$357,801$22,363
Uptravi14$342,990$24,499
Opsumit18$222,727$12,374
Ambrisentan12$41,619$3,468

2022: 3 drugs

Part D drugs prescribed in 2022
Orenitram Er26$567,138$21,813
Uptravi19$411,363$21,651
Ambrisentan17$59,830$3,519

2021: 3 drugs

Part D drugs prescribed in 2021
Orenitram Er24$457,470$19,061
Uptravi21$398,440$18,973
Ambrisentan23$63,138$2,745

2020: 6 drugs

Part D drugs prescribed in 2020
Orenitram Er24$475,747$19,823
Uptravi21$431,584$20,552
Letairis17$175,104$10,300
Ambrisentan29$99,132$3,418
Tadalafil22$43,308$1,969
Alyq15$12,533$836

2019: 10 drugs

Part D drugs prescribed in 2019
Letairis59$627,772$10,640
Uptravi27$541,034$20,038
Orenitram Er26$491,317$18,897
Tadalafil52$130,650$2,513
Adcirca17$67,683$3,981
Alyq15$34,252$2,283
Torsemide21$898$43
Spironolactone30$399$13
Digoxin17$246$14
Escitalopram12$54$4

2018: 13 drugs

Part D drugs prescribed in 2018
Letairis105$1,006,036$9,581
Uptravi48$794,683$16,556
Orenitram Er24$432,339$18,014
Adcirca63$234,439$3,721
Opsumit12$110,748$9,229
Tadalafil29$110,325$3,804
Sildenafil20$2,973$149
Digoxin32$873$27
Torsemide17$680$40
Spironolactone32$632$20
Furosemide15$89$6
Amlodipine Besylate12$60$5
Omeprazole12$36$3

2017: 4 drugs

Part D drugs prescribed in 2017
Uptravi29$508,239$17,525
Letairis51$472,039$9,256
Orenitram Er24$401,298$16,721
Adcirca13$47,096$3,623

2016: 5 drugs

Part D drugs prescribed in 2016
Orenitram Er16$274,763$17,173
Tracleer25$238,910$9,556
Letairis26$222,472$8,557
Adcirca46$143,271$3,115
Sildenafil11$544$49

2015: 7 drugs

Part D drugs prescribed in 2015
Letairis40$301,361$7,534
Tracleer31$265,043$8,550
Adcirca63$168,183$2,670
Sildenafil19$12,114$638
Spironolactone19$500$26
Amlodipine Besylate17$123$7
Furosemide18$50$3

2014: 8 drugs

Part D drugs prescribed in 2014
Tracleer40$305,591$7,640
Letairis22$157,191$7,145
Adcirca62$128,118$2,066
Sildenafil22$18,291$831
Potassium Chloride18$1,125$62
Spironolactone21$855$41
Furosemide29$377$13
Omeprazole19$231$12

2013: 10 drugs

Part D drugs prescribed in 2013
Tracleer25$171,427$6,857
Letairis20$131,336$6,567
Revatio11$68,147$6,195
Adcirca29$50,159$1,730
Sildenafil37$28,858$780
Spironolactone39$975$25
Potassium Chloride12$768$64
Furosemide38$174$5
Omeprazole14$145$10
Digox13$85$7

Money from drug and device companies

$181 in 2025

Industry payments by year
202527None$181
202434$10,250$10,456
202111$3,824$3,824
202012$11,303$11,303

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
Merck Sharp & DohmeWinrevair$155
6 payments
  • Meals for Winrevair · 2025-11-19 · $24
  • Meals for Winrevair · 2025-10-01 · $17
  • Meals for Winrevair · 2025-08-06 · $31
  • Meals for Winrevair · 2025-07-09 · $28
  • Meals for Winrevair · 2025-04-30 · $27
  • Meals for Winrevair · 2025-01-29 · $27
Actelion Pharmaceuticals USOpsynvi$26
1 payment
  • Meals for Opsynvi · 2025-10-29 · $26
See all 7 published payments
Every published payment
Merck Sharp & DohmeMeals · 2025-11-19Winrevair$24
Actelion Pharmaceuticals USMeals · 2025-10-29Opsynvi$26
Merck Sharp & DohmeMeals · 2025-10-01Winrevair$17
Merck Sharp & DohmeMeals · 2025-08-06Winrevair$31
Merck Sharp & DohmeMeals · 2025-07-09Winrevair$28
Merck Sharp & DohmeMeals · 2025-04-30Winrevair$27
Merck Sharp & DohmeMeals · 2025-01-29Winrevair$27
See earlier years (2024, 2021, 2020)

2024: $10,456

Payments by company in 2024
Alexion PharmaceuticalsNone$10,250
1 payment
  • Consulting · 2024-04-23 · $10,250
Merck Sharp & DohmeWinrevair$156
2 payments
  • Meals for Winrevair · 2024-10-23 · $34
  • Meals for Winrevair · 2024-07-25 · $122
Actelion Pharmaceuticals USNone$50
1 payment
  • Meals · 2024-08-15 · $50

2021: $3,824

Payments by company in 2021
GlaxoSmithKlineNone$3,824
1 payment
  • Consulting · 2021-01-25 · $3,824

2020: $11,303

Payments by company in 2020
GlaxoSmithKlineNone$11,303
2 payments
  • Consulting · 2020-11-11 · $3,686
  • Consulting · 2020-08-12 · $7,616

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
74.5 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1497863567
Licence
CA G68150California G68150: Current · expires 2028-01-31
Trained
Emory University School of Medicine, 1988
Video visits
Lists video visits
Gender
Female
More record details
Sole proprietor
No
Taxonomy
Federal specialty code 207RP1001X (207RP1001X)
Mailing address
2680 Hanover St, Palo Alto, CA, 94304
NPI first listed
2006-08-28
NPI last updated
2007-07-08

This is when the NPI record was last certified, not a medical board exam.